Cargando…

Systematic Literature Review of Respiratory Syncytial Virus Laboratory Testing Practices and Incidence in United States Infants and Children <5 Years of Age

BACKGROUND: Respiratory syncytial virus (RSV) can cause serious illness in those aged <5 years in the United States, but uncertainty remains around which populations receive RSV testing. We conducted a systematic literature review of RSV testing patterns in studies published from 2000 to 2021. ME...

Descripción completa

Detalles Bibliográficos
Autores principales:	Movva, Naimisha, Suh, Mina, Bylsma, Lauren C, Fryzek, Jon P, Nelson, Christopher B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Supplement Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377029/ https://www.ncbi.nlm.nih.gov/pubmed/35968874 http://dx.doi.org/10.1093/infdis/jiac203

Ejemplares similares

A Systematic Literature Review of the Burden of Respiratory Syncytial Virus and Health Care Utilization Among United States Infants Younger Than 1 Year( )
por: Suh, Mina, et al.
Publicado: (2022)

Mortality Among US Infants and Children Under 5 Years of Age with Respiratory Syncytial Virus and Bronchiolitis: A Systematic Literature Review
por: Bylsma, Lauren C, et al.
Publicado: (2022)

Respiratory Syncytial Virus Is the Leading Cause of United States Infant Hospitalizations, 2009–2019: A Study of the National (Nationwide) Inpatient Sample
por: Suh, Mina, et al.
Publicado: (2022)

Respiratory Syncytial Virus Burden and Healthcare Utilization in United States Infants <1 Year of Age: Study of Nationally Representative Databases, 2011–2019
por: Suh, Mina, et al.
Publicado: (2022)

Mortality Associated With Respiratory Syncytial Virus, Bronchiolitis, and Influenza Among Infants in the United States: A Birth Cohort Study From 1999 to 2018
por: Reichert, Heidi, et al.
Publicado: (2022)

1508. Hospitalizations and Emergency Department Visits for Respiratory Syncytial Virus Among Infants Aged < 1 year in the United States: An Analysis of Nationwide Inpatient and Emergency Room Data
por: Suh, Mina, et al.
Publicado: (2020)

Respiratory Syncytial Virus During the COVID-19 Pandemic Compared to Historic Levels: A Retrospective Cohort Study of a Health System( )
por: Movva, Naimisha, et al.
Publicado: (2022)

Cost of Respiratory Syncytial Virus Infections in US Infants: Systematic Literature Review and Analysis
por: Bowser, Diana M, et al.
Publicado: (2022)

1636. Prevention of respiratory syncytial virus hospitalizations (RSVH) in US infants who paid through Medicaid would have a disproportionate benefit for Black, Hispanic, Asian/Pacific Islander, Native American and Other race/ethnicity infants, and have a substantial impact on overall RSVH burden and related costs: Rates of respiratory syncytial virus hospitalization (RSVH) among US infants by race/ethnicity and insurance payer, NIS 2018-2020
por: Nelson, Christopher B, et al.
Publicado: (2023)

Respiratory Syncytial Virus and All-Cause Bronchiolitis Hospitalizations Among Preterm Infants Using the Pediatric Health Information System (PHIS)
por: Fergie, Jaime, et al.
Publicado: (2020)

The Burden of Respiratory Syncytial Virus Lower Respiratory Tract Disease in Infants in the United States: A Synthesis
por: Simões, Eric A F
Publicado: (2022)

Impact of Respiratory Syncytial Virus on Child, Caregiver, and Family Quality of Life in the United States: Systematic Literature Review and Analysis( )
por: Glaser, Elizabeth L, et al.
Publicado: (2022)

Medically Attended Illness due to Respiratory Syncytial Virus Infection Among Infants Born in the United States Between 2016 and 2020( )
por: Gantenberg, Jason R, et al.
Publicado: (2022)

Global Respiratory Syncytial Virus–Related Infant Community Deaths
por: Mazur, Natalie I, et al.
Publicado: (2021)

All Infants Are at Risk of Developing Medically Attended Respiratory Syncytial Virus Lower Respiratory Tract Infection and Deserve Protection
por: Hodges, Erin N, et al.
Publicado: (2022)

1406. Comparison of Clinical Presentations and Burden of Respiratory Syncytial Virus in Infants Across Three Distinct Healthcare Settings
por: Rankin, Danielle A, et al.
Publicado: (2020)

Immunoprophylaxis of respiratory syncytial virus: global experience
por: Simoes, Eric AF
Publicado: (2002)

Systematic Literature Review of the Prevalence and Prognostic Value of Delta-Like Ligand 3 Protein Expression in Small Cell Lung Cancer
por: Bylsma, Lauren C., et al.
Publicado: (2023)

Risk Factors for Respiratory Syncytial Virus–Associated Community Deaths in Zambian Infants
por: Murphy, Caitriona, et al.
Publicado: (2021)

An epidemiological study of respiratory syncytial virus associated hospitalizations in Denmark
por: Stensballe, Lone Graff
Publicado: (2002)

Prevention and treatment of respiratory syncytial virus bronchiolitis and postbronchiolitic wheezing
por: Kimpen, Jan LL
Publicado: (2002)

Hospitalizations for Respiratory Syncytial Virus Among Adults in the United States, 1997–2012
por: Pastula, Susan T., et al.
Publicado: (2017)

Trends in Respiratory Syncytial Virus and Bronchiolitis Hospitalization Rates in High-Risk Infants in a United States Nationally Representative Database, 1997–2012
por: Doucette, Abigail, et al.
Publicado: (2016)

Pathophysiological mechanisms for the respiratory syncytial virus-reactive airway disease link
por: Piedimonte, Giovanni
Publicado: (2002)

Potential therapeutic implications of new insights into respiratory syncytial virus disease
por: Openshaw, Peter JM
Publicado: (2002)

Respiratory syncytial virus hospitalization trends in infants with chronic lung disease of infancy, 1998–2008
por: Groothuis, Jessie R, et al.
Publicado: (2011)

Clinical perspectives on the association between respiratory syncytial virus and reactive airway disease
por: Sigurs, Nele
Publicado: (2002)

1526. The economic impact of respiratory syncytial virus (RSV) in infants in the United States: systematic literature review
por: Bowser, Diana, et al.
Publicado: (2020)

Theoretical attributable risk analysis and Disability Adjusted Life Years (DALYs) based on increased dairy consumption
por: Cohen, Sarah S., et al.
Publicado: (2022)

Comparison of clinical presentations and burden of respiratory syncytial virus in infants across three distinct healthcare settings in Davidson County, Tennessee
por: Rankin, Danielle A., et al.
Publicado: (2022)

Respiratory Syncytial Virus–Associated Mortality Among Young Infants in Karachi, Pakistan: A Prospective Postmortem Surveillance Study
por: Kazi, Abdul Momin, et al.
Publicado: (2021)

Challenges and Opportunities in Developing Respiratory Syncytial Virus Therapeutics
por: Simões, Eric A. F., et al.
Publicado: (2015)

Introduction. RSV and RAD: possibilities for prevention? The link between respiratory syncytial virus and reactive airway disease
por: Carbonell-Estrany, Xavier, et al.
Publicado: (2002)

Assessing the Full Burden of Respiratory Syncytial Virus in Young Infants in Low- and Middle-Income Countries: The Importance of Community Mortality Studies
por: Srikantiah, Padmini, et al.
Publicado: (2021)

Interferon gamma expression and mortality in unselected cohorts of urothelial bladder cancer patients
por: Gillezeau, Christina, et al.
Publicado: (2022)

The Use of Death Certificate Data to Characterize Mortality Associated With Respiratory Syncytial Virus, Unspecified Bronchiolitis, and Influenza in the United States, 1999–2018
por: Hansen, Chelsea L, et al.
Publicado: (2022)

Scoping Review of Employer-Led Research Using Employee Health Claims Data
por: Movva, Naimisha, et al.
Publicado: (2023)

Association of Respiratory Syncytial Virus Infection and Underlying Risk Factors for Death Among Young Infants Who Died at University Teaching Hospital, Lusaka Zambia
por: Forman, Leah S, et al.
Publicado: (2021)

Community Mortality Due to Respiratory Syncytial Virus in Argentina: Population-based Surveillance Study
por: Caballero, Mauricio T, et al.
Publicado: (2021)

1520. Respiratory Syncytial Virus Hospitalizations (RSVH) and All-Cause Bronchiolitis Hospitalizations (BH) Among Children Aged ≤ 24 Months at the Start of RSV Season With Bronchopulmonary Dysplasia/Chronic Lung Disease of Prematurity (BPD/CLDP) Before and After the 2014 American Academy of Pediatrics (AAP) Policy
por: Fergie, Jaime, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tkob72bn54ii4u57girnaeg2mf